5 results
To evaluate the feasibility and acceptability of the enhanced Lifestyle-integrated Functional Exercise Programme (eLiFE) intervention in a population of young old adults (60-70 years) at three sites: Stuttgart, Amsterdam, and Trondheim.
Primary:* To assess the effect of vedolizumab SC maintenance treatment on clinical remission at Week 52 in subjects with moderately to severely active UC who achieved clinical response at Week 6 following administration of vedolizumab IV at Weeks 0…
Primary:* To determine the effect of vedolizumab IV compared to adalimumab SC on clinical remission at Week 52.Secondary:* To evaluate the effect of vedolizumab IV compared to adalimumab SC on mucosal healing at Week 52.* To evaluate the effect of…
The primary objective of the clinical part of EPISTOP project is to identify the clinical and molecular biomarkers of epileptogenesis in a prospective clinical study of patients with TSC. Secondary objective of the clinical part of EPISTOP is to…
To evaluate the feasibility and usability of the adapted Lifestyle-integrated Functional Exercise Programme (aLiFE) and the enhanced LiFE (eLiFE) intervention, versus a control group, in a population of young old adults (61-70 years) at three sites…